Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and state employees implement a diabetes management program that includes mental ...

Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

Waystar upped its 2024 outlook and now expects total revenue to range between $926 million and $934 million, compared to ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

CGM Use in People with Type 2 Diabetes Initiating GLP-1 or GIP/GLP-1RA Therapy—Real-World Data ... 2024.04.002 This study analyzed contemporary heart failure (HF) decongestion strategies and ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

A new weight loss drug target could lower appetite and increase energy expenditure without causing nausea as a side effect.

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

In a study published in Nature, scientists outlined a powerful new drug candidate that lowers appetite without loss of muscle ...

The global weight loss and obesity management market is set to experience remarkable expansion in the coming decade. With new ...